Danaher Corporation (BVMF:DHER34)

Market Cap	855.79B
Revenue (ttm)	129.64B
Net Income (ttm)	18.71B
Shares Out	n/a
EPS (ttm)	26.00
PE Ratio	45.73
Forward PE	28.02
Dividend	0.17 (0.38%)
Ex-Dividend Date	Sep 25, 2025

Volume	3,205
Average Volume	6,142
Open	43.43
Previous Close	43.51
Day's Range	43.24 - 43.72
52-Week Range	33.66 - 53.36
Beta	0.93
RSI	58.61
Earnings Date	Jan 28, 2026

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: DHER34

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD